EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model

Tim Smith, Alec Young iD, Cameron O'Brien iD, Jacob Duncan, Matthew Rashid, Trevor Magee, Kyle Fitzgerald, Matt Vassar

ClinicoEconomics and Outcomes Research · 2025-06 · Volume 17 · 447-453

DOI: 10.2147/ceor.s516583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2025-06. Verfasst von Tim Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Mark Cubananticonvulsantcosteconomicspharmacyseizures

Autor:innen und Institutionen

  • Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
  • Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.

ORCID-Profile: Alec Young, Cameron O'Brien

Zitieren

APA

Smith, T., Young, A., O'Brien, C., Duncan, J., Rashid, M., Magee, T., Fitzgerald, K., & Vassar, M. (2025). Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. ClinicoEconomics and Outcomes Research, Volume 17, 447-453. https://doi.org/10.2147/ceor.s516583

Vancouver

Smith T, Young A, O'Brien C, Duncan J, Rashid M, Magee T, et al. Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. ClinicoEconomics and Outcomes Research. 2025;Volume 17:447-453. doi:10.2147/ceor.s516583

BibTeX
@article{Smith2025,
  author = {Smith, Tim and Young, Alec and O'Brien, Cameron and Duncan, Jacob and Rashid, Matthew and Magee, Trevor and Fitzgerald, Kyle and Vassar, Matt},
  title = {Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model},
  journal = {ClinicoEconomics and Outcomes Research},
  year = {2025},
  volume = {Volume 17},
  pages = {447--453},
  doi = {10.2147/ceor.s516583}
}
Kostenlos starten →